Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer

about

Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer

Item

http://www.wikidata.org/entity/Q37197012

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer

@en

Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer.

@nl

type

Item

label

Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer

@en

Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer.

@nl

prefLabel

Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer

@en

Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer.

@nl

P1476

Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer

@en

P2093

Ali Haydar

http://www.w3.org/2001/XMLSchema#string

Ali Shamseddine

http://www.w3.org/2001/XMLSchema#string

David Kelsen

http://www.w3.org/2001/XMLSchema#string

Deborah Mukherji

http://www.w3.org/2001/XMLSchema#string

Eileen M O'Reilly

http://www.w3.org/2001/XMLSchema#string

Fadi Geara

http://www.w3.org/2001/XMLSchema#string

Ghassan K Abou-Alfa

http://www.w3.org/2001/XMLSchema#string

Haifa Dbouk

http://www.w3.org/2001/XMLSchema#string

Hana Ajouz

http://www.w3.org/2001/XMLSchema#string

Leonard Saltz

http://www.w3.org/2001/XMLSchema#string

P2860

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis.

The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis.

Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials

Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients.

Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma.

Adjuvant therapy for pancreas adenocarcinoma.

P304

115-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24147159

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

3782872

http://www.w3.org/2001/XMLSchema#string